Selective manipulation of the gut microbiota improves immune status in vertebrates A Montalban-Arques, P De Schryver, P Bossier, G Gorkiewicz, V Mulero, ... Frontiers in Immunology 6, 512, 2015 | 217 | 2015 |
Human intestinal pro-inflammatory CD11chighCCR2+ CX3CR1+ macrophages, but not their tolerogenic CD11c− CCR2− CX3CR1− counterparts, are expanded in inflammatory bowel disease D Bernardo, AC Marin, S Fernández-Tomé, A Montalban-Arqués, ... Mucosal immunology 11 (4), 1114-1126, 2018 | 158 | 2018 |
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors A Montalban-Arques, E Katkeviciute, P Busenhart, A Bircher, J Wirbel, ... Cell host & microbe 29 (10), 1573-1588. e7, 2021 | 124 | 2021 |
Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy A Montalban-Arques, M Scharl EBioMedicine 48, 648-655, 2019 | 118 | 2019 |
The innate immune system in the gastrointestinal tract: role of intraepithelial lymphocytes and lamina propria innate lymphoid cells in intestinal inflammation A Montalban-Arques, M Chaparro, JP Gisbert, D Bernardo Inflammatory bowel diseases 24 (8), 1649-1659, 2018 | 82 | 2018 |
TRPV4-mediated detection of hyposmotic stress by skin keratinocytes activates developmental immunity J Galindo-Villegas, A Montalban-Arques, S Liarte, S De Oliveira, ... The Journal of Immunology 196 (2), 738-749, 2016 | 53 | 2016 |
Propionibacterium acnes overabundance and natural killer group 2 member D system activation in corpus‐dominant lymphocytic gastritis A Montalban‐Arques, P Wurm, S Trajanoski, S Schauer, S Kienesberger, ... The Journal of pathology 240 (4), 425-436, 2016 | 51 | 2016 |
Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis Á Arias, M Vicario, D Bernardo, JM Olalla, M Fortea, A Montalban-Arques, ... Clinical and Translational Gastroenterology 9 (4), e147, 2018 | 44 | 2018 |
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer P Busenhart, A Montalban-Arques, E Katkeviciute, Y Morsy, ... Journal for Immunotherapy of Cancer 10 (2), e003465, 2022 | 37 | 2022 |
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development E Katkeviciute, L Hering, A Montalban-Arques, P Busenhart, ... The Journal of clinical investigation 131 (1), 2021 | 25 | 2021 |
Peptides encrypted in the human intestinal microbial-exoproteome as novel biomarkers and immunomodulatory compounds in the gastrointestinal tract S Fernández-Tomé, A Montalban-Arques, A Díaz-Guerra, ... Journal of Functional Foods 52, 459-468, 2019 | 10 | 2019 |
Loss of PTPN23 promotes proliferation and epithelial-to-mesenchymal transition in human intestinal cancer cells L van der Lely, J Häfliger, A Montalban-Arques, K Bäbler, ... Inflammatory intestinal diseases 4 (4), 161-174, 2019 | 9 | 2019 |
Intestinal microbiota and colorectal carcinoma: implications for pathogenesis, diagnosis, and therapy. EBioMedicine 48: 648–655 A Montalban-Arques, M Scharl | 8 | 2019 |
Cytokine intervention: a double edged sword in the NKG2D system regulation A Montalban-Arques, G Gorkiewicz, V Mulero, J Galindo-Villegas Immunome Res S 2, 1-11, 2014 | 7 | 2014 |
A quick flow cytometry protocol to assess Helicobacter pylori viability C Alba, AC Marin, AG McNicholl, A Montalban-Arques, I Mora-Gutierrez, ... Journal of Microbiological Methods 177, 106043, 2020 | 5 | 2020 |
Deletion of Protein Tyrosine Phosphatase Nonreceptor Type 2 in Intestinal Epithelial Cells Results in Upregulation of the Related Phosphatase Protein Tyrosine Phosphatase … S Ulugöl, L Hering, R Manzini, A Montalban Arques, C Gottier, S Lang, ... Inflammatory intestinal diseases 4 (1), 14-26, 2019 | 2 | 2019 |
P106 Bifidobacterium longum subsp. longum microbiota-secreted bioactive peptide as a novel immunomodulatory compound in the human gastrointestinal tract S Fernández Tomé, A Montalbán-Arqués, A Díaz-Guerra, ... Journal of Crohn's and Colitis 12 (supplement_1), S147-S147, 2018 | 1 | 2018 |
Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via the GPR84 receptor E Katkeviciute, A Bircher, R Sanchez, M Schwill, A Dorst, Y Morsy, ... Cell Reports 44 (3), 2025 | | 2025 |
Intestinal epithelial PTPN23 is essential for gut barrier integrity and prevention of fatal bacterial translocation R Sanchez Alvarez, A Montalban-Arques, Y Morsy, C Gottier, J Häfliger, ... Journal of Crohn's and Colitis, jjaf016, 2025 | | 2025 |
A hydroxycarboxylic acid for the treatment of cancer M Scharl, A Montalban-arques, E Katkeviciute, Y Morsy US Patent App. 18/556,701, 2024 | | 2024 |